52 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
held by RepliCel, all know-how related to such patents, marketing materials, brand, server data and hardware (collectively, the "Assets").
Item 5 Full
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
(the "Proposed Transaction") of all patents currently held by RepliCel, all know-how related to such patents, marketing materials, brand, server data
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
this Notice of Meeting and accompanying materials through a broker, a financial institution, a participant, a trustee or administrator of a retirement savings … ), or a nominee of any of the foregoing that holds your securities on your behalf (an "Intermediary"), please complete and return the materials in accordance
6-K
EX-99.6
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
proxy-related materials for the Meeting sent in compliance with NI 54-101 to all beneficial owners at least 21 days before the date fixed
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
and received this Notice of Meeting and accompanying materials through a broker, a financial institution, a participant, a trustee or administrator … the materials in accordance with the instructions provided to you by your Intermediary.
DATED at Vancouver, British Columbia, this 23rd day of August, 2023
6-K
EX-99.1
sic7fvs
17 Aug 23
Annual General and Special Meeting
11:22am
D
tnjyl43bkrdfp
10 May 22
$592.73K in equity / options / securities to be acquired, sold $592.73K, 2 investors
3:57pm
D
ly8k4mwha pgcnuxo
20 Dec 21
$777.66K in equity, sold $777.66K, 1 investor
12:00am
6-K
EX-99.1
eecxj6ua7iy
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.1
wt5d0qhw3u5lgp jprlq
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
D/A
pp92mw6xt3
14 Jun 21
$161.52K in equity, sold $161.52K, 3 investors
11:46am
D
kbooinca ce
3 Jun 21
$111.57K in equity, sold $111.57K, 2 investors
5:03pm
D
9u0vibph0 zggh1fvvl
27 May 21
$9.01K in equity, sold $9.01K, 1 investor
12:22pm
D
nlt 4dm9ch1jm1
26 Feb 21
$385.85K in equity, sold $385.85K, 1 investor
12:00am
6-K
EX-99.3
sp6njocn4jn01jv3eg5
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
lxbaxm
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
D
58q9dvv qf3d
20 Aug 20
$118.18K in equity, sold $118.18K, 2 investors
10:53am
D
guo1ds2ujvm 9d8xkwh
24 Jul 20
$447.06K in equity / options / securities to be acquired, sold $447.06K, 2 investors
4:47pm
6-K
EX-99.1
zmelhclcg62x u5bszw4
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am